Cognitively healthy | AD | |||
---|---|---|---|---|
Female | Male | Female | Male | |
Number of patients | 34 | 12 | 141 | 62 |
CALHM1 rs2986017 C/C | 16 | 5 | 73 | 35 |
CALHM1 rs2986017 C/T | 15 | 6 | 62 | 22 |
CALHM1 rs2986017 T/T | 3 | 1 | 6 | 5 |
APOE ε2/3 | 4 | 2 | NDa | ND |
APOE °2/4 | 1 | 0 | ND | ND |
APOE °3/3 | 16 | 6 | ND | ND |
APOE °3/4 | 11 | 4 | ND | ND |
APOE °4/4 | 2 | 0 | ND | ND |
Age at sample (average) | 62.9 | 64.3 | 73.4 | 70.4 |
MMSE (± SDb) | 29.8 (± 0.5) | 29.8 (± 0.4) | 21.1 (± 5.6) | 22.7 (± 5.0) |
Aβ 1–40 pg/mL (average ± SD) | 8732 ± 3568 | 8696 ± 3816 | ND | ND |
Aβ 1–42 pg/mL (average ± SD) | 381 ± 196 | 336 ± 177 | 475 ± 221 | 518 ± 278 |